Reported Jan 11, 2017 · Terminated
ULTRA-TEST (CYP 80%/PROP 20%) Injectable, 250 mg/mL 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL
Wells Pharmacy Network LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Wells Pharmacy Network LLC · 1210 SW 33rd Ave · Ocala, FL · 34474-2853
Is this the product you have?
- ULTRA-TEST (CYP 80%/PROP 20%) Injectable, 250 mg/mL 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL
- Lot codes and dates
- All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry. Known Lot No. 03282016@22, 05162016@5, 07252016@16
- Known lot codes
03282016@2205162016@507262016@16
- Amount recalled
- 157 vials
This recall covers 97 products
The agency filed one notice per product. You are reading one of them; the other 96 are below.
84 more are in the archive.
Where it was sold
- Nationwide
Why it was recalled
Lack of Assurance of Sterility
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Wells Pharmacy Network LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.